Safety and preliminary efficacy on cognitive performance and adaptive functionality of epigallocatechin gallate (EGCG) in children with Down syndrome. A randomized phase Ib clinical trial (PERSEUS study)

202233 citationsJournal Articlehybrid Open Access

Authors

The use of EGCG is safe and well-tolerated in children with DS, but efficacy results do not support its use in this population.

Good health and well-being

Published in: Genetics in Medicine

Volume 24, Issue 10, pp. 2004-2013

Field-Weighted Citation Impact: 5.99